Potentiation of myeloid differentiation by anti-inflammatory agents, by steroids and by retinoic acid involves a single intracellular target, probably an enzyme of the aldoketoreductase family
- 28 May 1996
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1311 (3) , 189-198
- https://doi.org/10.1016/0167-4889(96)00005-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-alpha and retinoid X receptor-alpha RNA by HL-60 cellsBlood, 1993
- Promiscuous liaisonsNature, 1993
- Specificity of nuclear hormone receptor action who conducts the orchestra?Journal of Endocrinology, 1992
- The Steroid and Thyroid Hormone Receptor SuperfamilyScience, 1988
- Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells.Journal of Clinical Investigation, 1986
- Appearance of the arachidonic acid metabolic pathway in human promyelocytic leukemia (HL-60) cells during monocytic differentiation: enhancement of thromboxane synthesis by 1α,25-dihydroxy vitamin D-3Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Quantitation of microgram amounts of protein in two‐dimensional polyacrylamide gel electrophoresis sample bufferElectrophoresis, 1985
- 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cellsLeukemia Research, 1983
- 20α‐Hydroxysteroid dehydrogenase expression in hemopoietic cell cultures and its relationship to interleukin 3European Journal of Immunology, 1982
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970